Daunorubicin and body temperature increased Patient Reports February 11, 2012

Daunorubicin Side Effects Report #4788066-0
Daunorubicin side effect was reported by a Health Professional from UNITED STATES on Oct 04, 2005. Female patient, 55 years of age, weighting 169.0 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: atrial fibrillation , body temperature increased, constipation , hypotension, ileus, neutropenia, ventricular extrasystoles. Daunorubicin dosage: 108MG IV WEEKLY. During the same period patient was treated with ACYCLOVIR, FAMOTIDINE, FENTANYL, MEROPENEM. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4799935-X
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2005. Female patient, weighting 169.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alpha haemolytic streptococcal infection, atrial fibrillation , blood bilirubin increased, blood fibrinogen increased, blood phosphorus increased, body temperature increased, brain natriuretic peptide increased, constipation . Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4799942-7
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2005. Female patient, weighting 169.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alpha haemolytic streptococcal infection, atrial fibrillation , blood bilirubin increased, blood fibrinogen increased, blood phosphorus increased, body temperature increased, brain natriuretic peptide increased, constipation . Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4799946-4
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2005. Female patient, weighting 169.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alpha haemolytic streptococcal infection, atrial fibrillation , blood bilirubin increased, blood fibrinogen increased, blood phosphorus increased, body temperature increased, brain natriuretic peptide increased, constipation . Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.


Daunorubicin Side Effects Report #5191393-9
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 20, 2006. Female patient, weighting 138.0 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: arthralgia, bacteria tissue specimen identified, blood culture positive, body temperature increased, gastrointestinal necrosis, hypotension, induration, perianal erythema. Daunorubicin dosage: 83.5 MG. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE, CYTARABINE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #5195925-6
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 27, 2006. Female patient, weighting 138.0 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: arthralgia, bacteroides infection, blood bilirubin increased, blood culture positive, body temperature increased, culture tissue specimen positive, erythema, hypotension. Daunorubicin dosage: 83.5 MG. During the same period patient was treated with DEXAMETHASONE, CYTARABINE, METHOTREXATE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.